Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rick Strange who wrote (1419)	10/15/1998 8:13:00 AM
From: Ariella	of 1491

Dear Rick - yes, getting a patient in a coma to take a pill would be rather....ah...interesting! Actually, I meant this delivery system for future use in the treatment of multiple sclerosis, where medication is taken on a daily level. From a profit perspective, finding a suitable drug for a chronic disease brings in a great deal more revenue. I've noticed the sports injury connection too and have been wondering the same about whether HU-211 might have any place in the treatment of less severe concussions than is true in the current trials. The numbers for sports-related concussions in the US are quite high.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next